EyePoint Pharmaceuticals
EYPT
EYPT
98 hedge funds and large institutions have $269M invested in EyePoint Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 34 increasing their positions, 19 reducing their positions, and 8 closing their positions.
Holders
98
Holders Change
+15
Holders Change %
+18.07%
% of All Funds
1.56%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
24
Increased
34
Reduced
19
Closed
8
Calls
$3.12M
Puts
$10.3M
Net Calls
-$7.2M
Net Calls Change
-$7.41M
Top Buyers
1 |
1
T. Rowe Price Associates
Baltimore,
Maryland
|
$11M |
2 |
![]()
2
JPMorgan Chase & Co
New York
|
$4.86M |
3 |
3
UBS Group
Zurich,
Switzerland
|
$4.21M |
4 |
GTC
4
Ghost Tree Capital
New York
|
$2.6M |
5 |
5
Millennium Management
New York
|
$4.64M |